Physician profile
Anthony Lucev
NPI 1235561796
$2,065.84
in general payments reported to CMS, 2019-2025
16 companies · $92.41 in 2025
The $92.41 reported for 2025 was less than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.50 · 2020: $31.54 · 2021: $643 · 2022: $590 · 2023: $635 · 2024: $17.79 · 2025: $92.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $745.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $682.73 | 2021-2023 | Resonate El Icd Vr |
| Merck Sharp & Dohme LLC | $329.05 | 2021-2023 | Verquvo |
| Astrazeneca Pharmaceuticals Lp | $233.99 | 2021-2023 | Farxiga |
| Abiomed | $216.94 | 2019-2023 | Impella |
| Heartflow, INC. | $127.78 | 2022-2025 | |
| Amgen INC. | $111.72 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $109.45 | 2019-2023 | Lifevest |
| Biosense Webster, INC. | $65.12 | 2022 | |
| Amarin Pharma, INC. | $40.02 | 2021-2023 | |
| Atricure, INC. | $32.96 | 2023 | |
| Arbor Pharmaceuticals, INC. | $29.91 | 2021-2022 | |
| Abbott Laboratories | $24.73 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Biotronik INC. | $16.85 | 2021 | |
| Althera Pharmaceuticals LLC | $15.36 | 2022 | |
| Daiichi Sankyo INC. | $15.06 | 2023 | Injectafer |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Lucev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.